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Abstract. The intercellular adhesion of circulating leukocytes to vascular endothellum 
ls a prerequisite for leukocyte emigration from the blood to extravascular tlssues. Thls 
process ls facllltated by adheslon molecules on the surfaces of both the vascular 
endothelial cells and the leukocytes. The experiments presented here demonstrate for 
the firsttimethat the leukocyte adheslon receptor, lntercellular adhesion molecule-1, 
ls constitutlvely expressed on cultured cerebromlcrovascular endothellal cell llnes 
derlved from both spontaneously hypertensive (SHR) rats and normotenslve Wlstar-
Kyoto (WKY) rats. Both cultures contalned simllar numbers of cells constltutlvely 
expressing thls adheslon molecule (31.4% and 29.6%, respectlvely). Adheslon mole-
cule expresslon was up-regulated by lnterleukln-1 ß, tumor necrosis factor-a, lnter-
feron-y and lipopolysaccharide in a dose- and tlme-dependent manner. Both cultures 
exhiblted similar maximum Ieveis of adhesion molecule up-regulation to optimal con-
centratlons of all three cytokines. However, SHR endothelial cells were moresensitive 
to all three cytokines; slgnificantly higher Ieveis of lntercellular adhesion molecule-1 
expresslon were seen on SHR as opposed to WKY endothellal cells cultured with 
sub-optimal cytoklne concentratlons. lt was also observed that lipopolysaccharide 
up-regulated intercellular adhesion molecule-1 expression on SHR endothellal cells to 
a greater extent than on WKY endothellal cells. 
The findings that intercellular adheslon molecule-1 can be up-regulated to a 
greater degree on SHR endothellal cells may have lmportant lmplications for ln vlvo 
perlvascular leukocyte accumulatlon under hypertensive condltlons. These Observa-
tions lndlcate a possible mechanism by which hypertension may predlspose to the 
development of dlsorders such as atherosclerosis and stroke. [P.S.E.B.M. 1994, Vol205] 
T he adhesion of leukocytes to vascular endothe-lial cells (EC) is an initial, critical step required for their emigration from the blood stream to 
extravascular tissues (1-3). The adhesion event is fa-
cilitated by a variety of adhesion molecules present on 
the surfaces of EC (e.g., intercellular adhesion mole-
cule-1 [ICAM-1], vascular cell adhesion molecule-1, 
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etc.) which interact with their complementary ligands 
(membrane-associated glycoproteins [integrins]) 
present on leukocytes (e.g., LFA-1, VLA-4, etc.). Al-
though essential for host repair and defense, intercel-
lular adhesion processes may also result in endothelial 
injury which occurs during allograft rejection (4) andin 
chronic inflammatory disorders such as autoimmune 
murine Iupus nephritis (5) and atherosclerosis (6). The 
expression of adhesion molecules by cerebromi-
crovascular EC, as well as the resultant adherence of 
leukocytes and their migration have also been studied 
in disease states, including hemorrhagic shock, cere-
hrat ischemic stroke, atherosclerosis, and multiple 
sclerosis (7-12). Thesedisorders are characterized, in 
part, by leukocyte adhesion to cerebromicrovascular 
EC and subsequent extravascular migration. The 
above studies have documented the expression of ad-
hesion molecules on cerebromicrovascular EC and the 
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resultant interactions with various circulating leuko-
cytes. 
In recent years, ICAM-1 (CD54) expression, in 
particular, has been demonstrated to promote adhe-
sion of a variety of blood leukocytes including lym-
phocytes, neutrophils, and monocytes (1, 13-16). 
ICAM-1 is very strongly expressed by certain nonhe-
matopoietic cells, such as vascular EC, and weakly 
expressed by some blood mononuclear cells, such as 
monocytes and lymphocytes (17). ICAM-1 expression 
can be induced and/or up-regulated in vitro by a vari-
ety of cytokines such as interleukin-1ß (IL-1ß), tumor 
necrosis factor-a (TNFa), and interferon--y (IFN-y) (2, 
13, 16, 18). In addition, lipopolysaccharide (LPS), a 
prototypic stimulus to activate the cytokine system, 
also enhances ICAM expression (19). 
In rats, in vitro ICAM-1 expression has been re-
ported in EC isolated from heart (20) and peripheral 
lymph nodes (21, 22). In the present study, cerebro-
microvascular endothelial celllines derived from spon-
taneously hypertensive rats (SHR) and Wistar-Kyoto 
rats (WKY) were examined for their ability to consti-
tutively express ICAM-1. In addition, data are also 
presented demonstrating the regulation of ICAM -1 ex-
pression on SHR and WKY cerebromicrovascular EC 
by various cytokines and LPS. The comparison of 
ICAM-1 expression and regulation on both SHR and 
WKY cerebromicrovascular EC offers a unique op-
portunity to examine the possible influence of hyper-
tension, a known stroke risk factor, on EC responsive-
ness to proinflammatory factors. 
Materials and Methods 
Rats. Fernale Wistar-Kyoto (WKY) and sponta-
neously hypertensive (SHR) rats obtained from 
Taconic Farms (Germantown, NY) at 9 to 14 weeks of 
age and Sprague Dawley (SD) rats obtained from Har-
lan Sprague Dawley, Inc. (lndianapolis, IN) were uti-
lized to isolate cerebromicrovascular EC used in this 
study. All animal procedures were in accordance with 
guidelines put forth in the NIH Guide for the Care and 
Use of Labaratory Animals. 
Cerebromicrovascular EC Cultures. The isola-
tion and cultivation of cerebromicrovascular EC from 
SHR, WKY and SD rats was performed with some 
modification as previously described (23). Propagated 
EC (1 x 104/100 J,Lllwell) were passaged and grown to 
confluency on 1% gelatin-coated coverslips or 96-well 
flat bottom microtiter plates at 37°C in humidified at-
mosphere of 5% COiair in M-199 medium (containing 
25 mM Hepes buffer, Earle's salts and L-glutamine) 
with 20% heat-inactivated FCS, 90 J,Lg/ml heparin, 100 
J.Lg/ml Streptomycin, 100 U/ml penicillin G, and 0.25 
J.Lg/ml amphotericin B as fungizone (all from GIBCO, 
Long Island, NY) and 20 J.Lg/ml endothelial cell growth 
supplement (Collaborative Research, Bedford, MA). 
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EC were positively identified by both immunocyto-
chemistry and fluorescence-activated cell sorter 
(F ACS) analysis using EC-specific anti-Factor VIII-
related antigen (Accurate Chemical and Scientific 
Corp., Westbury, NY) as previously described (24). 
All cultures used in experiments described here were 
obtained from three separate lines and were used at 
3rd-1lth passage. Confluent EC cultures derived from 
SHR, WKY and SD cerebral microvessels routinely 
exhibited characteristic cobblestone appearances, and 
>95% of cells in both of these cultures stained posi-
tively for FVIII-related antigen. Prior to use in adhe-
sion and ICAM-1 assays, cells were washed twice with 
Hank's Balanced Salt Solution (HBSS) followed by 
incubation in media alone or with indicated concentra-
tions of recombinant IFN-y (Genzyme Corp., Boston, 
MA), human IL-1ß (Endogen, Boston, MA), recombi-
nant human TNFa (Endogen), or LPS (Sigma, St. 
Louis, MO). Alltreatments were performed in quadru-
plicate wells. All reagents contained < 10 pg/ml endo-
toxin as determined by E-toxate assay kit (Sigma). 
ICAM-1 Expression. EC cultures grown on gela-
tin-coated coverslips were extensively washed, pre-
fixed in 1: 1 mixture glacial acetic acid and methanol 
(10 min, 4°C) and incubated at 37°C with 1:50 mouse 
monoclonal antibody (lgG1) to rat ICAM-1 (clone 
IA29; Seikagaku Corp., Rockville, MD) for 45 min. 
After incubation with 1:100 rhodamine-conjugated 
F(ab'hgoat anti-mouse lgG (Accurate) for 8 hr, SHR, 
WKY, and SD EC cultures were observed to consti-
tutively express ICAM-1 by indirect immunofluores-
cence microscopy. 
The relative Ievel of ICAM-1 expression by EC 
cultures was quantitated by ELISA essentially as pre-
viously described (25). Briefly, EC (2 x 104 cells/50 
J,Lllwell) cultures in 96-well microtiter plates were in-
cubated in the absence or presence of various concen-
trations of IFN-y, IL-1ß, TNFa, or LPS for indicated 
time periods at 37°C in 5% C02 • Nonspecific binding 
sites were blocked by addition of heat-aggregated rab-
bit lgG (Sigma) and EC cultures were sequentially in-
cubated at 37°C for 1 hr in the presence of IA29 
(1: 1 000); biotinylated anti-mouse lgG (1: 1 000); and 
0.33 J,Lg/ml avidin-horseradish peroxidase. All sub-
stances were obtained from Sigma and were added at 
100 J,Lllwell. Plates were washed three times with PBS 
containing 2% BSA between each of the above steps. 
The reaction was developed by adding phosphate-
citrate buffer/0.004% 0-phenylenediamine, 0.012% 
H20 2 (25°C, 30 min) and stopped by adding 4 N HCI. 
The optical density (O.D.) was immediately read at 
490 nm (reference 630 nm). Background values for 
each culture condition, obtained by incubation of EC 
with an irrelevant mouse antibody (RTl.B) specific for 
rat Class II MHC antigen (MRC OX6; Accurate) in 
lieu of IA29, were subtracted from test values. 
FACS Analysis. Analysis of cell populations by 
flow cytometry was performed on a F ACS IV analyzer 
(Becton Dickinsan F ACS System, Mountain View, 
CA). Cerebromicrovascular cells from SHR and WKY 
SD rats were stained with anti-ICAM-1 or RT1.B fol-
lowed by rhodamine-conjugated goat F(ab'hanti-
mouse lgG (Accurate). The data are displayed as a 
histogram with the y axis representing cell number and 
the x axis representing fluorescence intensity (in 
channel units). The mean fluorescence intensity (MFI) 
represents semiquantitative data on the mean number 
of fluorescent reagent-binding molecules expressed by 
the cells. 
Results 
Confluent EC cultures derived from SHR, WKY, 
and SD cerebral microvessels routinely exhibited 
characteristic cobblestone appearances, stained posi-
tively for FVIII-related antigen and ICAM-1. The ex-
pression of ICAM-1 by SHR and WKY cerebromi-
crovascular EC cultures was examined by F ACS anal-
ysis. A similar percentage of cells in both EC cultures 
constitutively expressed ICAM-1 (Table 1). The mean 
fluorescence intensity (MFI), which is a measure of 
the relative level of ICAM-1 expression per cell, was 
also similar for both SHR (17 .5 channel units) and 
WKY (19.1 channel units) EC. Treatment for three 
days with TNFo. (1-200 U/ml) up-regulated ICAM-1 
expression on both SHR and WKY EC cultures. In-
creases in both the percentage of cells expressing 
ICAM-1 and in the MFI values were correlated with 
the concentration of TNFo.. No significant differences 
in the maximum responses to TNFo. (200 U/ml) were 
seen between SHR and WKY EC cultures. However, 
incubation of SHR EC with 1 U/ml TNFo. significantly 
increased the percentage of cells expressing ICAM-1, 
whereas only minor increases in the number of WKY 
EC expressing ICAM-1 were seenunder these culture 
conditions. At all intermediate concentrations of 
TNFo., the responsiveness of SHR EC (as assessed by 
Table I. Effect of TNFo. on ICAM-1 Expression by 
SHR and WKY Cerebromicrovascular EC 
TNFa8 SHRb WKY 
U!m/ % MFI % MFI 
0 31.4 17.5 29.6 19.1 
1 41.8 21.8 31.3 18.2 
10 49.6 32.6 39.8 23.1 
100 61.2 46.9 59.9 33.4 
200 63.8 48.3 64.2 45.4 
a EC cultures were incubated in the presence of indicated con-
centrations TNFa for three days prior to analysis. 
b Cerebromicrovascular EC were analyzed by FACS as de-
scribed in Materialsand Methods. Data indicate the (%) percent 
~f ICAM-1 positive cells and (MFI) mean fluorescence intensity 
(m channel units) of EC cultures. 
both the percentage of positive cells and MFI values) 
were greater than WKY EC. No staining was observed 
with an irrelevant antibody (MRC OX6) specific for rat 
Class II antigens. 
The overall level of ICAM-1 expression by EC 
cultures was quantitated by ELISA. The capacity of 
TNFo. to up-regulate ICAM-1 expression on both SHR 
and WKY EC was dose dependent (Fig. 1). Treatment 
with low concentrations ofTNFo. (i.e., 1-50 U/ml) en-
hanced ICAM-1 expression on SHR EC to a signifi-
cantly greater extent (P < 0.01) than on WKY EC. No 
significant differences in the level of ICAM-1 expres-
sion were observed between SHR and WKY EC incu-
bated in the presence of 100 or 200 U/ml of TNFo.. 
Experiments performed on other cerebrovascular 
EC cell lines derived from SHR, WKY and also from 
SD rats resulted in similar findings to those shown in 
Figure 1 and also demonstrate "normal" responsive-
ness of SD EC. In addition, other proinflammatory 
cytokines such as IFN "Y and IL-1 ß also increased 
ICAM-1 expression on these cells (Table II). Although 
there were differences in the overall responsiveness of 
EC cultures to these cytokines with TNFa > IL-1ß > 
IFN"(, all cytokines dose-dependently up-regulated 
ICAM-1 expression on SHR, WKY, and SD EC cul-
tures. In addition, incubation with suboptimal concen-
trations of TNFo., IL-1ß, and IFN"Y up-regulated 
ICAM-1 expression on SHR EC to a greater extent 
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Figure 1. Effect of TNFa on ICAM-1 expression by SHR and WKY 
cerebromicrovascular endothelial cells (EC}. Cerebrovascular 
EC lines isolated from SHR (IZI) and WKY (D) rat brain microves-
sels were cultured in microtiter plates for 24 hr in the absence or 
presence of indicated concentrations of TNFa. EC cultures were 
examined for ICAM-1 expression by ELISA as described in Ma-
terials and Methods. The values presented indicate O.D. ± S.D. 
values above those obtained in EC cultures incubated in media 
alone (0.123 ± 0.008 and 0.199 ± 0.020 for SHR and WKY EC, 
respectively); *significant difference (P < 0.01; Student's t test} 
between EC cultures. 
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Table II. Effects of TNFa, IFN')', and IL-1 ß on 
Up-Regulation of ICAM-1 Expressionon SHR, 
WKY, and SD Cerebrovascular EC 
Cytokineb ICAM-1 expressiona 
(U/m/) SHR EC WKYEC SO EC 
TNFa 1 0.146 ± 0.003 0.031 ± 0.004d 0.018 ± 0.002d 
10 0.321 ± 0.008 0.181 ± 0.007d 0.149 ± o.oo8d 
50 0.489 ± 0.013 0.363 ± 0.018c N09 
100 0.533 ± 0.013 0.479 ± 0.031 0.426 ± 0.032c 
IFN-y 1 0.084 ± 0.008 0.014 ± 0.003d 0.008 ± 0.002d 
10 0.169 ± 0.009 0.088 ± 0.011 c o.o68 ± o.o1 od 
50 0.289 ± 0.012 0.211 ± 0.009c ND 
100 0.404 ± 0.021 0.365 ± 0.024 0.323 ± 0.021 c 
IL-1ß 1 0.120 ± 0.007 0.020 ± 0.002d 0.021 ± 0.003d 
5 0.308 ± 0.020 0.151 ± 0.018d 0.150 ± 0.016d 
20 0.423 ± 0.008 0.305 ± 0.01 oc ND 
50 0.494 ± 0.032 0.456 ± 0.028 0.421 ± 0.042 
a Data are presented as 0.0. 490 nm above background ± S.O. 
obtained from ELISA experiments performedas described in the 
Materialsand Methods. Background values for SHR, WKY, and 
SO EC were 0.238 ± 0.029, 0.391 ± 0.024, and 0.316 ± 0.025, 
respectively. 
b Cerebrovascular EC cultures were incubated for three days in 
the presence of indicated concentrations of TNFa, IFN-y, or IL-ß. 
c Significant difference (P < 0.01; Student's t test) compared 
with SHR EC. 
d Significant difference (P < 0.001 ; Student's t test) compared 
with SHR EC. 
e ND = not done. 
than on either WKY or SD EC; no significant differ-
ences in ICAM-1 expression were observed between 
WKY and SD EC. 
The length of time required for ICAM-1 up-
regulation by TNFa, IL-Iß, and IFN')' treatmentwas 
examined. Treatment with IL-Iß increased ICAM-1 
expression as early as 4 hr after addition to culture and 
reached a maximum after 16-24-hr culture (Fig. 2). A 
slower effect on ICAM-1 expressionwas observed us-
ing TNFa and IFN')'; very little increases in ICAM-1 
expression were seen at 4 hr, but these cells also ex-
hibited maximum Ievels of ICAM-1 expression after 
24-hr culture. Culturing these cells with cytokines for 
greater than 24 hr did not significantly increase 
ICAM-1 expression. No differences were observed be-
tween SHR and WKY EC. 
The ability of LPS to affect ICAM-1 expression 
was also examined. LPS dose-dependently enhanced 
ICAM-1 expression on SHR, WKY, and SD EC (Fig. 
3). The responsiveness of SHR EC to LPS-induced 
up-regulation of ICAM-1 was greater than WKY or 
ED EC. This enhanced responsiveness of SHR EC to 
LPS was observed at all LPS concentrations (0.1-100 
J.Lg/ml). Unlike the results obtained with cytokines, 
SHR EC responded to a significantly greater degree 
than either WKY or SD EC to optimal LPS concen-
trations (i.e., 100 J.Lg/ml) in three offour experiments. 
Incubation of SHR, WKY, and SD EC cultures with 
>100 J.Lg/ml LPS did not significantly increase ICAM-1 
expression. In fact, incubation with LPS concentra-
tions of 300 J.Lg/ml or higher resulted in lower Ievels of 
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Figure 2. Timecourse of the effect of TNFa, IL-1 ß, and IFN-y on 
ICAM-1 expression by cerebromicrovascular endothelial cells 
(EC). Cerebrovascular EC lines isolated from WKY rat brain mi-
crovessels were cultured in microtiter plates in the absence or 
presence of 100 U/ml IFN-y (6), 100 U/ml TNFa (0) or 50 U/ml 
IL-1 ß (0) for indicated periods of time. EC cultures were exam-
ined for ICAM-1 expression by ELISA as described in Materials 
and Methods. The values presented indicate 0.0. ± S.O. values 
above those obtained in EC cultures incubated in media alone 
which ranged between 0.102 ± 0.009 and 0.215 ± 0.020 for all 
the different time periods. 
ICAM-1 expression which were related to decreases in 
the percent of viable EC (determined by trypan blue 
exclusion) cultured under these conditions. 
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Flgure 3. Effect of LPS on ICAM-1 expression by SHR, WKY, and 
SO cerebromicrovascular endothelial cells (EC). Cerebrovascu-
lar EC lines isolated from SHR (0), WKY (0) and SO(~) rat brain 
microvessels were cultured in microtiter plates for three days in 
the absence or presence of indicated concentrations (0.1-100 
Jl.Q/ml) of LPS. EC cultures were examined for ICAM-1 expres-
sion by ELISA as described in Materials and Methods. The val-
ues presented indicate 0.0. ± S.O. values above those obtained 
in EC cultures incubated in media alone (0.241 ± 0.014, 0.277 :t 
0.017 and 0.187 :t 0.016 for SHR, WKY, and SO EC, respectively); 
*significant difference (P < 0.01; Student's t test) compared to 
SHR EC cultures. 
Discussion 
The experiments here demonstrate the expression 
of the adhesion molecule, ICAM-1, on cultures of EC 
isolated from SHR, WKY, and SD rat brain microves-
sels. Although ICAM-1 expression by brain EC has 
been previously reported, this is the first demonstra-
tion in rats (10, 11, 26--28). This implicates rat cere-
bromicrovascular EC in interactions with cells ex-
pressing CD11a or CDllb integrins (i.e., lymphocytes, 
monocytes, and neutrophils) (1, 13-16). Interactions 
between these various cell types and EC and the pos-
sible role ofiCAM-1 in these adhesive interactions has 
been described in various disorders including rheuma-
toid arthritis, autoimmune murine Iupus nephritis, ex-
perimental autoimmune encephalomyelitis (EAE), 
multiple sclerosis (MS), and atherosclerosis, and in 
ischemia-reperfusion injury models (5, 7-12, 26--28). 
The possible role of TNFa, IL-1ß, and IFN"Y in 
pathogenic processes has been suggested in a number 
of disorders including EAE, MS, rheumatoid arthritis, 
and atherosclerosis (11, 29-32). The capacity of these 
cytokines to enhance ICAM-1 expression is weil doc-
umented (2, 16, 18) and implicates ICAM-1 or possibly 
other adhesion molecules in the pathogenesis of these 
disorders. This may account for why cytokines are 
often referred to as "double-edged swords" and why 
mechanisms to inhibit synthesis or actions of cyto-
kines are being explored in order to achieve therapeu-
tic benefits (see review 33). 
In all experiments using suboptimal concentra-
tions of cytokines or LPS, the Ievel of up-regulated 
ICAM -1 expression was greater for SHR EC than for 
WKY or SD EC. Although the quantitative responses 
of various EC cultures differed, it was consistently 
observed that the relative degree of ICAM-1 up-
regulation by TNF a > IL-1 ß > IFN "Y. The maximum 
Ievels of ICAM-1 expression by SHR, WKY, and SD 
EC cultures were similar in cultures incubated with 
optimal concentrations of these cytokines. These data 
indicate possible differences in the sensitivity of these 
various EC cultures to cytokine treatment. The obser-
vation that optimal, as weil as suboptimal, concentra-
tions ofLPS up-regulated ICAM-1 expression on SHR 
EC to a greater extent than on either WKY or SD EC 
indicates a possible difference in the mechanism(s) by 
which these EC respond to LPS as opposed to cyto-
kines. Such differences may be influenced by the num-
ber of LPS binding sites and possibly the affinity of 
these sites. The functional significance of the Observa-
tions described here is indicated by preliminary exper-
iments showing similar findings regarding enhanced 
adhesion of monocytes. The increased adhesion of 
monocytes to either LPS- or TNFa- and IL-1ß-treated 
SHR EC was significantly higher than in WKY EC (P 
< 0.001). 
The comparison of expression of adhesion recep-
tors by cerebromicrovascular EC from normotensive 
(WKY and SD) and spontaneously hypertensive 
(SHR) rats provides a unique opportunity to examine 
the contribution of hypertension to immune respon-
siveness, or vice versa. There is already considerable 
evidence for a relationship between these parameters 
(34). Although differences between the in vitro respon-
siveness of the SHR EC and WKY or SD EC cultures 
were observed only at suboptimal concentrations of 
cytokines, more differences could exist in vivo, where 
endothelium is subjected to blood flow/shear stress, 
factors related to hypertension and various agents in-
cluding cytokines which may be rapidly washed away. 
Such in vivo differences are indicated by observations 
that LPS induces greater increases in plasma Ievels of 
TNFa in SHR than in WKY rats (35). Additional stud-
ies regarding the influence of hypertension, as well as 
other potential risk factors for stroke, on expression of 
adhesion molecules by endothelium may provide in-
sight toward defining a mechanism by which these fac-
tors contribute to the initiation of vascular injury. 
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